PARIS, FRANCE: Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced the appointment of Ana Sharma as Vice President, Global Head of Quality. Ms. Ana Sharma brings over 20 years of experience in the…
All posts tagged Abivax
Abivax announces plans to conduct registered public offering in the United States
PARIS, FRANCE: Abivax, a French biotechnology company that develops novel treatments for inflammatory diseases, viral diseases and cancer, announced today that it intends to launch a public offering of its shares in the United States. The company has filed a confidential draft registration statement with the U.S. Securities and Exchange Commission (SEC) for the offering…